Morphine and breast tumor metastasis: the role of matrix-degrading enzymes.
Opioids including morphine are commonly used in pain management during and after cancer surgery but have been linked to a variety of pro- and anti-tumor effects. In the present study the effect of morphine administration on the localization and growth of breast tumor cells in lungs and the level of extracellular matrix (ECM) proteases were investigated. In a mouse syngeneic model of intravenously inoculated breast cancer cells, morphine administration led to a reduction in the localization and growth of tumors in the lungs and a reduction in circulating matrix metalloproteinase-9 (MMP-9) and urokinase-like plasminogen activator (uPA). To model the involvement of non-malignant cells of the tumor microenvironment in the changes we observed in the level of proteases, we co-cultured breast cancer cells with macrophages, endothelial cells and fibroblasts. We found a significant elevation of matrix proteases as well as matrix protease inhibitors in co-cultures of breast cancer cells with macrophages or endothelial cells. Interestingly, morphine treatment of these co-cultures reduced the level of MMP-9 and increased its endogenous inhibitor, TIMP-1, thereby altering the proteolytic profile. Morphine affected the level of enzymes in co-cultures but not in cells grown individually. This suggests that anti-tumor effects of morphine observed in our in vivo model could be mediated at least in part through modulation of paracrine communication between cancer cells and non-malignant cells in the tumor microenvironment.
School of Pharmacy, University of Queensland, PACE, 20 Cornwall Street, Woolloongabba, Brisbane, QLD, 4102, Australia.
Banafsheh
B
Afsharimani
Joanne
J
Baran
Satoshi
S
Watanabe
Daniel
D
Lindner
Peter J
PJ
Cabot
Marie-Odile
MO
Parat
D000818:Animals; D001943:Breast Neoplasms / Q000201:enzymology / Q000473:pathology*; D017077:Culture Media, Conditioned; D005109:Extracellular Matrix / Q000378:metabolism*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000517:prevention & control / Q000556:secondary*; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism*; D051379:Mice; D009020:Morphine / Q000494:pharmacology*; D059748:Proteolysis; D014407:Tumor Cells, Cultured; D014568:Urokinase-Type Plasminogen Activator / Q000378:metabolism*; D023041:Xenograft Model Antitumor Assays
D017077:Culture Media, Conditioned; D009020:Morphine; D014568:Urokinase-Type Plasminogen Activator; D020780:Matrix Metalloproteinase 9